The Role of FTO and Vitamin D for the Weight Loss Effect of Roux-en-Y Gastric Bypass Surgery in Obese Patients

Obesity Surgery

Volumn 25, Issue 11, 2015, Pages 2071-2077

  Bandstein, Marcus ^a   Schultes, Bernd ^b   Ernst, Barbara ^b   Thurnheer, Martin ^b   Schiöth, Helgi B ^a   Benedict, Christian ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b eSwiss Medical Surgical Center   (Switzerland)

Author keywords

Bariatric surgery; FTO; RYGB; Vitamin D; Weight loss

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL; ALPHA KETOGLUTARATE DEPENDENT DIOXYGENASE FTO; FTO PROTEIN, HUMAN; PROTEIN; VITAMIN D;

ADULT; ARTICLE; BODY MASS; FAT MASS AND OBESITY GENE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BYPASS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; GASTRIC BYPASS SURGERY; GENETICS; OBESITY, MORBID; PHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO; ANASTOMOSIS, ROUX-EN-Y; DIETARY SUPPLEMENTS; FEMALE; GASTRIC BYPASS; GENOTYPE; HUMANS; MALE; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROTEINS; VITAMIN D; VITAMIN D DEFICIENCY; WEIGHT LOSS;

EID: 84943359318     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1644-4     Document Type: Article

References (33)

1. Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med. 2009;150(8):541–50.
2. Elks CE, Perry JR, Sulem P, et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet. 2010;42:1077–85.
3. Peng S, Zhu Y, Xu F, et al. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2011;9:71.
4. Li H, Kilpeläinen TO, Liu C, et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia. 2012;55:981–95.
5. Lourenço BH, Qi L, Willett WC, et al. FTO Genotype, Vitamin D status, and weight gain during childhood. Diabetes. 2014;63:808–14.
6. Liou T-HH, Chen H-HH, Wang W, et al. ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. Obesity Surg. 2011;21:1758–65.
7. Still CD, Wood GC, Chu X, et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2014;22:888–94.
8. Mägi R, Manning S, Yousseif A, et al. Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgery. PLoS One. 2013;8:e70735.
9. Thurnheer M, Bisang P, Ernst B, et al. A novel distal very long Roux-en Y gastric bypass (DVLRYGB) as a primary bariatric procedure—complication rates, weight loss, and nutritional/metabolic changes in the first 355 patients. Obesity Surg. 2012;22:1427–36.
10. Gröber U, Spitz J, Reichrath J, et al. Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013;5:331–47.
11. Ernst B, Thurnheer M, Schmid SM, et al. Seasonal variation in the deficiency of 25-hydroxyvitamin D(3) in mildly to extremely obese subjects. Obesity Surg. 2009;19:180–3.
12. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13(2):159–60.
13. Loos RJ. Recent progress in the genetics of common obesity. Br J Clin Pharmacol. 2009;68:811–29.
14. de Luis DA, Aller R, Conde R, et al. The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet. J Investig Med. 2013;61:22–6.
15. Matsuo T, Nakata Y, Murotake Y, et al. Effects of FTO genotype on weight loss and metabolic risk factors in response to calorie restriction among Japanese women. Obesity (Silver Spring). 2012;20:1122–6.
16. Smemo S, Tena JJ, Kim K-HH, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507:371–5.
17. Stratigopoulos G, Carli J, O’Day D, et al. Hypomorphism for RPGRIP1L, a ciliary gene vicinal to the FTO locus, causes increased adiposity in mice. Cell Metab. 2014;19:767779.
18. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8–28.
19. Lin L, Hales CM, Garber K, et al. Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway. Hum Mol Genet. 2014;23:3299–306.
20. Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–7.
21. Lips P, van Schoor NM, de Jongh RT. Diet, sun, and lifestyle as determinants of vitamin D status. Ann N Y Acad Sci. 2014;1317:92–8.
22. Heuvel E, Schoor N, Jongh R, et al. Cross-sectional study on different characteristics of physical activity as determinants of vitamin D status; inadequate in half of the population. Eur J Clin Nutr. 2013;67(4):360–5.
23. Ahern T, Khattak A, O’Malley E, et al. Association between vitamin D status and physical function in the severely obese. J Clin Endocrinol Metab. 2014;99(7):E1327–31.
24. Larose TL, Chen Y, Camargo CA, et al. Factors associated with vitamin D deficiency in a Norwegian population: the HUNT Study. J Epidemiol Community Health. 2014;68:165–70.
25. Vatier C, Henegar C, Ciangura C, et al. Dynamic relations between sedentary behavior, physical activity, and body composition after bariatric surgery. Obesity Surg. 2012;22:1251–6.
26. Loos RJ, Yeo GS. The bigger picture of FTO—the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51–61.
27. Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev. 2012;25:130–41.
28. Choi EY. 25(OH)D status and demographic and lifestyle determinants of 25(OH)D among Korean adults. Asia Pac J Clin Nutr. 2012;21:526–35.
29. Thuesen B, Husemoen L, Fenger M, et al. Determinants of vitamin D status in a general population of Danish adults. Bone. 2012;50:605–10.
30. Harbron J, van der Merwe L, Zaahl MG, et al. Fat mass and obesity-associated (FTO) gene polymorphisms are associated with physical activity, food intake, eating behaviors, psychological health, and modeled change in body mass index in overweight/obese Caucasian adults. Nutrients. 2014;6:3130–52.
31. Gustavsson J, Mehlig K, Leander K, et al. FTO genotype, physical activity, and coronary heart disease risk in Swedish men and women. Circ Cardiovasc Genet. 2014;7:171–7.
32. Liel Y, Ulmer E, Shary J, et al. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43:199–201.
33. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3.